News Risk Factors for Geographic Atrophy in the CATT Trial by Medscape • 2014/09/19 • 0 Comments The CATT results are discussed -- will they help ophthalmologists choose either bevacizumab or ranibizumab? Medscape Ophthalmology Full Story →